Phase I-IIa, to Evaluate the Safety, Feasibility, & Efficacy of the Use of

Status Recruiting

Clinical Trial Summary

Phase I/II, controlled, open-label, randomized, single site clinical trial to assess the safety and feasibility, as well as hint efficacy evidence of a bioengineered palate mucosa substitute on nanostructured fibrin-agarose scaffolds with autologous mucosa tissue-specific cells (culture-expanded fibroblasts and keratinocytes), for tissue replacement and repair of donor area after the reconstruction of palate cleft defects (staphylorraphy), in comparison with standard care for donor mucosa.

Clinical Trial Description

The initial phase of the trial is non-randomized, and involves the sequential recruitment of 5 eligible subjects with a minimum safety period of 30 days between them. All of them will be implanted with the autologous human palatal mucosa substitute of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT), after reconstruction of the palate. Once the 5th treated patient has reached 1.5 months of follow-up after the intervention (Visit 8), the safety and feasibility data analysis will be carried out by the Independent Data Safety and Monitoring Committee (interim analysis), after which will allow continuation to the randomized phase of the trial, if the results allow it. In the second phase, the rest of the patients (10) will be recruited, who will be randomized 1:1, such that 5 of these patients will be implanted with the investigational medication while undergoing standard surgical reconstruction. (uranostaphyllorrhaphy), while the other 5 will only undergo standard surgical reconstruction and will constitute the control group. The total number of patients to be included in the study will be 15, who will be followed for 24 months according to a protocolized scheme that includes 2 pre-implant visits, 1 implant visit and 9 post-implant evaluation visits. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06408337
Study type	Interventional
Source	Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Contact	Elisa Cubiles
Phone	955048278
Email	emontero@fibao.es
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	April 17, 2024
Completion date	December 17, 2028

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05876169` - How Does Orthognathic Surgery Affect Jaw and Neck Motor Function?	N/A
Recruiting	`NCT04455035` - DynaCleft® Effects on Soft Tissues and on Quality of Life for Incomplete Unilateral Cleft Lip Infants	N/A
Not yet recruiting	`NCT05031039` - Skeletal and Dental Maturational Stages in a Sample of Egyptian Subjects With Cleft Lip and Palate Deformity
Recruiting	`NCT03839290` - Development of the Palate in Bilateral Orofacial Cleft Newborns One Year After Early Neonatal Cheiloplasty
Recruiting	`NCT04771156` - Ketorolac in Palatoplasty	Phase 4
Completed	`NCT04725370` - Characterization of Cleft Lip and Palate Conditions in Guatemala
Enrolling by invitation	`NCT02702869` - Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)
Active, not recruiting	`NCT05971914` - Alveolar Cleft Hard- and Soft Tissue Reconstruction With an Autogenous Tooth Derived Particulate Graft	N/A
Completed	`NCT03708406` - Otologic and Rhinologic Outcomes in Children With Clef Palate
Recruiting	`NCT06105099` - Effect of Performance-specific Cleft Speech Intervention and Long-term Learning in Children With a Cleft Palate	N/A
Completed	`NCT06075069` - Evaluation of the Effect of Prosthetic Management for Congenital Cleft Lip and Palate Infants on the Middle Ear Function	N/A
Completed	`NCT04384276` - Weigh Easy: Simplifying Home Weight Monitoring for Infants	N/A
Recruiting	`NCT04619030` - Augmented Reality (AR): The Future of "Patient Information Leaflets	N/A
Recruiting	`NCT03065686` - Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing	N/A
Completed	`NCT02845193` - Effect of Novel Nasoalveolar Molding Techniques on Parents' Satisfaction and Short Term Treatment Outcomes in Unilateral Cleft Lip and Palate Infants: A Randomized Controlled Trial	N/A
Completed	`NCT03308266` - Electromyographic Analysis of the Masticatory Muscles in Cleft Lip and Palate Children With Temporomandibular Disorders	N/A
Completed	`NCT01932164` - Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients	N/A
Not yet recruiting	`NCT06411444` - Effect of Different Nasal Stent Designs With Nasoalveolar Molding Appliance	N/A
Not yet recruiting	`NCT06292234` - Patient Specific Implant Versus Miniplates for Advancement of Hypoplastic Maxilla	N/A
Recruiting	`NCT05081258` - Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms